Ensuring Patient-Centric DPI Products Through Efficient Manufacturing

Dry powder inhaled drug products are a cornerstone of many patient treatments. As these products advance through development, the transition from bench and clinical to commercial stages underscores the need for efficient and scalable manufacturing processes. A deep understanding of the powder's chemical and physical properties and the impact of the manufacturing process parameters are critical to product quality and performance.